Additionally, acylpeptide hydrolase, dipeptidyl peptidase IV, and prolyl oligopeptidase inhibitors presumed to find relevance as drug lead in the cure of neurodegenerative diseases implied their assay in the present study. This evidence concerns the gene DPP4 and neurodegenerative disease.